Frick MH - Search Results

1

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, et al. Frick MH, et al. N Engl J Med. 1987 Nov 12;317(20):1237-45. doi: 10.1056/NEJM198711123172001. N Engl J Med. 1987. PMID: 3313041 Clinical Trial.

2

Serum ferritin and ceruloplasmin as coronary risk factors.

Mänttäri M, Manninen V, Huttunen JK, Palosuo T, Ehnholm C, Heinonen OP, Frick MH. Mänttäri M, et al. Among authors: frick mh. Eur Heart J. 1994 Dec;15(12):1599-603. doi: 10.1093/oxfordjournals.eurheartj.a060440. Eur Heart J. 1994. PMID: 7698127

3

Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study.

Hautanen A, Mänttäri M, Manninen V, Tenkanen L, Huttunen JK, Frick MH, Adlercreutz H. Hautanen A, et al. Among authors: frick mh. Atherosclerosis. 1994 Feb;105(2):191-200. doi: 10.1016/0021-9150(94)90049-3. Atherosclerosis. 1994. PMID: 8003095 Clinical Trial.

4

The Helsinki Heart Study: an 8.5-year safety and mortality follow-up.

Huttunen JK, Heinonen OP, Manninen V, Koskinen P, Hakulinen T, Teppo L, Mänttäri M, Frick MH. Huttunen JK, et al. Among authors: frick mh. J Intern Med. 1994 Jan;235(1):31-9. doi: 10.1111/j.1365-2796.1994.tb01029.x. J Intern Med. 1994. PMID: 8283157 Clinical Trial.

5

The Helsinki Heart Study: coronary heart disease incidence during an extended follow-up.

Heinonen OP, Huttunen JK, Manninen V, Mänttäri M, Koskinen P, Tenkanen L, Frick MH. Heinonen OP, et al. Among authors: frick mh. J Intern Med. 1994 Jan;235(1):41-9. doi: 10.1111/j.1365-2796.1994.tb01030.x. J Intern Med. 1994. PMID: 8283158 Clinical Trial.

6

Seasonal variation in high density lipoprotein cholesterol.

Mänttäri M, Javela K, Koskinen P, Pikkarainen J, Manninen V, Huttunen JK, Frick MH. Mänttäri M, et al. Among authors: frick mh. Atherosclerosis. 1993 May;100(2):257-65. doi: 10.1016/0021-9150(93)90212-d. Atherosclerosis. 1993. PMID: 8357358

7

Efficacy of gemfibrozil in dyslipidaemic subjects with suspected heart disease. An ancillary study in the Helsinki Heart Study frame population.

Frick MH, Heinonen OP, Huttunen JK, Koskinen P, Mänttäri M, Manninen V. Frick MH, et al. Ann Med. 1993 Feb;25(1):41-5. doi: 10.3109/07853899309147855. Ann Med. 1993. PMID: 8435186 Clinical Trial.

8

Relation between baseline lipid and lipoprotein values and the incidence of coronary heart disease in the Helsinki Heart Study.

Manninen V, Huttunen JK, Heinonen OP, Tenkanen L, Frick MH. Manninen V, et al. Among authors: frick mh. Am J Cardiol. 1989 May 2;63(16):42H-47H. doi: 10.1016/0002-9149(89)90115-x. Am J Cardiol. 1989. PMID: 2650524 Clinical Trial.

9

Helsinki Heart Study. New perspectives in the prevention of coronary heart disease.

Huttunen JK, Frick MH, Heinonen OP, Heinsalmi P, Manninen V, Mänttäri M, Romo M. Huttunen JK, et al. Among authors: frick mh. Drugs. 1988;36 Suppl 3:32-6. doi: 10.2165/00003495-198800363-00009. Drugs. 1988. PMID: 3076118 Clinical Trial.

10

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

Manninen V, Elo MO, Frick MH, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, et al. Manninen V, et al. Among authors: frick mh. JAMA. 1988 Aug 5;260(5):641-51. JAMA. 1988. PMID: 3164788 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page